In addition, specific targets are of great significance for CAR‐T cells, so researchers have discovered some new findings on targets, such as ALPL‐1 for metastatic osteosarcoma and GPRC5D for MM, which provide a better choice of targets for accurate treatment of tumors. This evidence concerns the gene GPRC5D and Miyoshi myopathy.